The Efficacy and Safety of Thrice vs Twice per Week Low-Intensity Pulsed Ultrasound Therapy for Erectile Dysfunction: A Randomized Clinical Trial

Author:

Chen Huirong1,Li Zheng1,Li Xianchen2,Yang Yong3,Dai Yutian4,Xie Zuogang5,Xiao Jiaquan6,Liu Xiaoqiang7,Yang Luo8,Shi Chenkun1,Zhi Erlei1,Tian Ruhui1,Li Peng1,Chen Huixing1,Zhao Fujun1,Hu Jianlin9,Yao Chencheng1,Lin Guiting10,Lue Tom F.10,Xia Shujie1

Affiliation:

1. Clinical Medical Center of Urology, Institute of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China

2. Clinical Research Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China

3. Department of Urology, The Affiliated Hospital of Changchun University of Traditional Chinese Medicine , Changchun, Jilin , China

4. Department of Andrology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School , Nanjing, Jiangsu , China

5. Department of Andrology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine , Wenzhou, Zhejiang , China

6. Department of Urology, The Second Affiliated Hospital of Zhejiang University School of Medicine , Hangzhou, Zhejiang , China

7. Department of Urology, Tianjin Medical University General Hospital , , Tianjin , China

8. Department of Urology and Pelvic surgery, West China Fourth Hospital, Sichuan University , ChengduSichuan , China

9. Department of Reproductive Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China

10. Knuppe Molecular Urology Laboratory, Department of Urology, School of Medicine, University of California , San Francisco , USA

Abstract

ABSTRACT Background A recent sham-controlled clinical study has shown that low-intensity pulsed ultrasound twice per week can safely and effectively treat patients with mild-to-moderate erectile dysfunction (ED). However, large-scale clinical trials are needed to verify its efficacy and safety and determine a reasonable treatment interval. Aim To study whether low-intensity pulsed ultrasound therapy thrice per week is non-inferior to twice per week in patients with mild-to-moderate ED. Methods A randomized, open-label, parallel-group, non-inferiority clinical trial was conducted in 7 hospitals in China. A total of 323 patients with mild-to-moderate ED were randomized (1:1) into thrice per week (3/W) and twice per week (2/W) groups. Low-intensity pulsed ultrasound was applied on each side of the penis for 16 sessions. Outcomes The primary outcome was response rate using the minimal clinically important difference in the International Index of Erectile Function (IIEF-EF) score at week 12. Secondary outcomes included Erection Hardness Score (EHS), Sexual Encounter Profile, Global Assessment Question, and Self Esteem and Relationship Questionnaire. Results Response rates in 3/W and 2/W groups were 62.0% and 62.5%, respectively. Treatment effect in the 3/W group was noninferior to that of the 2/W group, with rate difference lower bound of −0.01% [95% confidence interval −0.11 to 0.10%] within the acceptable margin (−14.0%). No significant difference was found among secondary outcomes. IIEF-EF score showed a significant increase from baseline in the 3/W group (16.8 to 20.7) and 2/W group (17.8 to 21.7), and the percentage of patients with EHS ≥3 increased in the 3/W (54.9% to 84.0%) and 2/W (59.5% to 83.5%) groups. There was no significant difference in response rate between the 2 groups after controlling for strata factors and homogeneous tests. No treatment-related adverse events were reported. Clinical Implications Low-intensity pulsed ultrasound therapy displays similar efficacy and safety for mild-to-moderate ED when administered thrice or twice per week for 16 sessions. This study provides two options to suit patients’ needs. Strengths & Limitations This is a large-sample, randomized, controlled, noninferiority trial study. Short-term follow-up and mostly younger patients are the main limitations. Conclusion Low-intensity pulsed ultrasound therapy thrice and twice per week showed equivalent therapeutic effects and safety for mild-to-moderate ED in a young and generally healthy population. This therapy warrants further investigation of its potential value in rehabilitation of ED.

Funder

National Natural Science Foundation of China

Shanghai Medical Innovation Program

Shanghai Scientific and Technological

Publisher

Oxford University Press (OUP)

Subject

Urology,Reproductive Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Psychiatry and Mental health

Reference29 articles.

1. Erectile dysfunction;Yafi;Nat Rev Dis Primers,2016

2. Treatment response to sildenafil in men with erectile dysfunction relative to concomitant comorbidities and age;Goldstein;Int J Clin Pract,2017

3. The future is today: emerging drugs for the treatment of erectile dysfunction;Albersen;Expert Opin Emerg Drugs,2010

4. Emerging tools for erectile dysfunction: a role for regenerative medicine;Hakim;Nat Rev Urol,2012

5. Low-intensity shock wave therapy in sexual medicine-clinical recommendations from the European Society of Sexual Medicine (ESSM);Capogrosso;J Sex Med,2019

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3